Related Experiment Video
Updated: Aug 21, 2025

The Establishment and Utilization of Patient Derived Xenograft Models of Central Nervous System Metastasis
Published on: May 7, 2021
[Clinical characteristics of digestive system cancers metastatic to the heart]
J L Tang1, B Zhang1, X Y Wang1
1Department of Medical Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100021, China.
Insights
Cardiac metastasis from digestive tumors is rare and has a poor prognosis. Systemic therapies are key, with new drugs potentially improving outcomes for these challenging cases.
Area of Science:
- Oncology
- Cardiology
- Gastroenterology
Context:
- Cardiac metastases are uncommon complications of primary digestive system malignancies.
- Understanding the clinical presentation and outcomes is crucial for patient management.
Purpose:
- To explore the clinical characteristics of patients with cardiac metastases originating from digestive system tumors.
- To analyze survival data and treatment efficacy in this patient cohort.
Summary:
- This retrospective study analyzed 19 patients with cardiac metastases from digestive cancers (esophageal, gastric, hepatobiliary, colorectal).
- Dyspnea was the most frequent symptom. Pericardial involvement was most common.
- Median survival after diagnosis of cardiac metastasis was 4.7 months, highlighting a poor prognosis.
Impact:
- This study underscores the low incidence and poor prognosis associated with cardiac metastases from digestive cancers.
- Systemic treatment is the primary therapeutic approach, with potential for novel anti-tumor agents to enhance efficacy.
Abstract:
Objective: To investigate the clinical features of patients with cardiac metastases from digestive system tumors. Methods: This retrospective study collected and analyzed the medical records of patients with cardiac metastases from digestive system tumors who received treatments in the Cancer Hospital, Chinese Academy of Medical Sciences between January 1999 and January 2021. Kaplan-Meier method was used for survival analysis. Results: A total of 19 patients were identified. The primary tumors were esophageal squamous cell carcinoma (n=7), gastric or gastroesophageal junction adenocarcinoma (n=6), hepatobiliary cancers (n=3) and colorectal cancers (n=3). 16 patients had pericardial metastases, 2 patients had right atrium metastases, and 1 patient had left ventricle metastasis. The most common symptom was dyspnea, which was present in 8 cases. 7 patients received locoregional treatment, while 11 patients underwent systemic therapies. The median overall survival from diagnosis of primary cancer was 31.4 months, and the median overall survival time from diagnosis of cardiac metastasis was 4.7 months. Conclusion: Cardiac metastasis from digestive system tumors is associated with low incidence and a poor prognosis. Systemic treatment remains the cornerstone of management, while novel anti-tumor drugs may improve therapeutic efficacy.
More Related Videos
Related Concept Videos
Metastasis
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Adaptive Mechanisms in Cancer Cells
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Tumor Progression
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Other Disorders of Digestive System
Cardiomyopathy I: Introduction and Classification
Cancer Stem Cells and Tumor Maintenance
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...

